DNDN was once a high flying stock, with hits hyped prostate cancer drug provenge, leading the hype. DNDn went from sub $5 stock in early 2009, to $55 stock in early 2010. Dissapointing sales results and other factors have resulted in a massive sell-off and DNDN has been trading near multi-year lows.Over the last few weeks, the stock has shown some life and with todays news, i fully expect this to be trading over $10 in the short term. As i write this the stock is trading at $8.64. It usually takes some time before folks peel back the onion and see whats going on here, so you should have time to get some calls or go long the stock under $9 before the end of day stampede.
$9 calls are .32 right now, and look to be the play.